David Rosen – TRVI history

Issuer:
TREVI THERAPEUTICS INC
Quarters tracked:
16 (Q3 2022 → Q2 2026)
Current shares:
2,504,513
Current value:
$46.71M
Peak shares:
8,531,860 (Q2 2025)
Overall change:
-56%
QuarterSharesValue$/ShareShare ΔΔ%
Q2 20262,504,513$46.71M$18.65-1,207,860-33%
Q1 20263,712,373$44.29M$11.93-54,376-1%
Q4 20253,766,749$47.16M$12.52-4,765,111-56%
Q3 20258,531,860$78.07M$9.1500%
Q2 20258,531,860$46.67M$5.47+3,993,325+88%
Q1 20254,538,535$28.55M$6.29+333,406+8%
Q4 20244,205,129$17.32M$4.12-821,802-16%
Q3 20245,026,931$16.79M$3.3400%
Q2 20245,026,931$14.98M$2.98-537,192-10%
Q1 20245,564,123$19.20M$3.45-120,297-2%
Q4 20235,684,420$7.62M$1.3400%
Q3 20235,684,420$12.39M$2.1800%
Q2 20235,684,420$13.59M$2.3900%
Q1 20235,684,420$10.52M$1.8500%
Q4 20225,684,420$10.97M$1.9300%
Q3 20225,684,420$8.75M$1.54—NEW